MLYSMineralys Therapeutics, Inc.

$31.13
Latest close: back above its 200-day averageSep 8, 2026what changed →

What is the market doing?

What the tape says about MLYS

Mineralys Therapeutics, Inc. is +103% over the past year while the S&P 500 is +20%: 83 points ahead of the market.

+103%

1-year return · S&P 500 +20%

vs 200-day average
+2.1%

vs 200-day average · close to trend

RSI (14)
72

RSI (14) · overbought, bought harder than it has been sold

Below its 52-week high
34%

Below its 52-week high

2024-08-15$8.76 – $47.33 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$31.13
1 monthS&P 500 −0.30%
+15%
1 yearS&P 500 +20%
+103%
vs 50-day average$26.38
+18%
52-week high
$47.33
52-week low
$14.47
Annualised volatility
93%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
$8.8M
Calendar-year price return
YearReturn
2026 (year to date)−14%
2025+195%
2024+43%
Average return by calendar month, 2023–2026
MonthYearsPositiveAverage
Jan31 of 3−1.4%
Feb31 of 3+8.1%
Mar41 of 4+9.6%
Apr40 of 4−7.8%
May44 of 4+10%
Jun41 of 4−5.2%
Jul43 of 4−1.1%
Aug42 of 4−1.1%
Sep42 of 4+35%
Oct32 of 3−0.16%
Nov31 of 3−4.3%
Dec31 of 3+3.2%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.